Michael G. Kaplitt

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

Robert S. Fisher, Vicenta Salanova, Thomas C. Witt et al. · Epilepsia · 2010 · 1.9K citations

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Adeno-associated Virus, Medical Treatment, Borne Gad Gene +4

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

Michael G. Kaplitt, Paola Leone, R. Jude Samulski et al. · Nature Genetics · 1994 · 1K citations

Molecular Virology, Long-term Gene Expression, Mammalian Brain +8

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 661 citations

Advanced Parkinson, Aav2-gad Gene Therapy, Neurological Progress +5

Disruption of mitochondrial complex I induces progressive parkinsonism

Patricia González‐Rodríguez, Enrico Zampese, Kristen A. Stout et al. · Nature · 2021 · 511 citations · Full text

Mitochondrial Function, Neuroscience, Neurodegeneration +3